Publications by authors named "Carolin D Strobl"

Claim this Profile
A
ARID1A mutations protect follicular lymphoma from FAS-dependent immune surveillance by reducing RUNX3/ETS1-driven FAS-expression.
Martina Antoniolli, Maria Solovey, Johannes Adrian Hildebrand, Tabea Freyholdt, Carolin Dorothea Strobl

Cell Death Differ· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering an inducible leukemia-associated fusion protein enables large-scale ex vivo production of functional human phagocytes.
Roland Windisch, Sarah Soliman, Adrian Hoffmann, Linping Chen-Wichmann, Anna Danese, Carolin Dorothea Strobl

Proc Natl Acad Sci U S A· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP14 is a novel target in STAT6 mutant follicular lymphoma.
Michael Mentz, William Keay, Carolin Dorothea Strobl, Martina Antoniolli, Louisa Adolph, Ursula Zimber-Strobl

Leukemia· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.
Erik Gaitzsch, Verena Passerini, Elham Khatamzas, Carolin D Strobl, Maximilian Muenchhoff

Hemasphere· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Oncometabolite 5'-Deoxy-5'-Methylthioadenosine Blocks Multiple Signaling Pathways of NK Cell Activation.
Benedikt Jacobs, Sebastian Schlögl, Carolin Dorothea Strobl, Simon Völkl, Andrej Stoll

Front Immunol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Double-Negative Regulatory T-Cells Induce a Metabolic and Functional Switch in Effector T-Cells by Suppressing mTOR Activity.
Tabea Haug, Michael Aigner, Moritz M Peuser, Carolin D Strobl, Kai Hildner

Front Immunol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective PRMT5 Inhibitors Suppress Human CD8 T Cells by Upregulation of p53 and Impairment of the AKT Pathway Similar to the Tumor Metabolite MTA.
Carolin Dorothea Strobl, Stefanie Schaffer, Tabea Haug, Simon Völkl, Katrin Peter

Mol Cancer Ther· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppressive effects of tumor cell-derived 5'-deoxy-5'-methylthioadenosine on human T cells.
Frederik C Henrich, Katrin Singer, Kerstin Poller, Luise Bernhardt, Carolin D Strobl

Oncoimmunology· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis